HIV感染者改良乙肝疫苗接种后长期血清保护持久性
加强剂后96%达到血清保护,证实持久的免疫记忆。
要点
- 加强剂后96%达到血清保护,显示稳健的回忆应答。
- 初免后抗-HBs滴度较高可独立预测长期保护与加强应答。
核心结论
- 改良乙肝疫苗接种方案在HIV感染者中诱导持久血清保护,初免十余年后仍存在免疫记忆。
研究设计与样本
- 干预性研究,纳入既往对四剂40μg改良初免方案应答的HIV感染者75例,中位随访14.5年。
主要发现
- 接种40μg乙肝疫苗加强剂后1-6个月内,96%达到血清保护。
- 初免后抗-HBs滴度较高独立预测长期血清保护和加强后应答。
关键数值与推荐
- 强应答者定义为抗-HBs≥100 mIU/mL。
- 加强剂为40μg乙肝疫苗。
临床怎么用
- 对完成改良乙肝疫苗初免的HIV感染者,十余年后多数仍维持保护,可考虑加强接种以巩固免疫。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People living with HIV (PLHIV) exhibit reduced seroprotection and faster antibody waning after hepatitis B virus (HBV) vaccination. Data on long-term persistence and immunological memory following enhanced vaccination schedules are limited. METHODS: In this interventional study, PLHIV who previously responded to a modified primary HBV vaccination schedule (four 40-μg doses) were reassessed after a median follow-up of 14.5 years. Anti-HBs titers were measured before and 1-6 months after administration of a 40 μg HBV booster dose. RESULTS: Among 75 participants, 81,3% maintained seroprotective anti-HBs levels, with 59% classified as strong responders (≥ 100 mIU/mL). Although titers declined over time, 96% achieved seroprotection after the booster dose, demonstrating a robust anamnestic response. Higher post-primary vaccination anti-HBs titers independently predicted both long-term seroprotection and post-booster responses. CONCLUSION: The modified HBV vaccination schedule induced durable seroprotection and confirmed persistent immunological memory in PLHIV more than a decade after primary immunization.
引用
- Troccoli CS, Nascimento PS, Villar LM, et al. Long-term persistence of Seroprotection following a modified hepatitis B vaccine schedule in people living with HIV. Vaccine. 2026. PMID: 41855644. doi:10.1016/j.vaccine.2026.128483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。